切换至 "中华医学电子期刊资源库"

中华肝脏外科手术学电子杂志 ›› 2012, Vol. 01 ›› Issue (03) : 162 -168. doi: 10.3877/cma.j.issn.2095-3232.2012.03.004

所属专题: 文献

临床研究

手术切除治疗中央型肝细胞肝癌临床分析
周学平1,(), 沈军1, 王健东1, 庄鹏远1, 全志伟1, 刘颖斌1   
  1. 1. 200092 上海交通大学医学院附属新华医院普外科
  • 收稿日期:2012-08-08 出版日期:2012-12-10
  • 通信作者: 周学平
  • 基金资助:
    国家"十二五"科技重大专项(2012ZX10002016-014)

Clinical analysis of surgical resection for centrally located hepatocellular carcinoma

Xue-ping ZHOU1,(), Jun SHEN1, Jian-dong WANG1, Peng-yuan ZHUANG1, Zhi-wei QUAN1, Ying-bin LIU1   

  1. 1. Department of General Surgery, Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai 200092, China
  • Received:2012-08-08 Published:2012-12-10
  • Corresponding author: Xue-ping ZHOU
  • About author:
    Corresponding author: ZHOU Xue-ping, Email:
引用本文:

周学平, 沈军, 王健东, 庄鹏远, 全志伟, 刘颖斌. 手术切除治疗中央型肝细胞肝癌临床分析[J/OL]. 中华肝脏外科手术学电子杂志, 2012, 01(03): 162-168.

Xue-ping ZHOU, Jun SHEN, Jian-dong WANG, Peng-yuan ZHUANG, Zhi-wei QUAN, Ying-bin LIU. Clinical analysis of surgical resection for centrally located hepatocellular carcinoma[J/OL]. Chinese Journal of Hepatic Surgery(Electronic Edition), 2012, 01(03): 162-168.

目的

探讨中央型肝细胞肝癌(肝癌)手术切除的安全性、可行性和疗效,总结手术治疗经验。

方法

本组回顾性研究对象为2007年1月至2011年12月在上海交通大学医学院附属新华医院普外科实施手术切除的35例中央型肝癌患者。患者均签署知情同意书,符合医学伦理学规定。男性31例,女性4例,年龄25~69岁,中位年龄46岁。手术方式:肝癌位于肝Ⅳ、Ⅴ段之间者3例,其中2例行左半肝切除术,1例行肿瘤局部切除术;位于Ⅷ段者11例,其中7例行Ⅷ段切除术,4例行右半肝上段(Ⅶ、Ⅷ段)切除术;位于第一肝门者5例,均行中肝叶(Ⅳ、Ⅴ、Ⅷ段)切除术;位于门静脉右前、右后支夹角者7例,其中4例行右肝下段(Ⅴ、Ⅵ段)切除术,另3例行右半肝切除及门静脉取栓术;位于门静脉左、右支、肝右静脉、肝中静脉及下腔静脉之间者2例,2例均行肿瘤局部切除术,其中1例先行左右半肝劈开后再行肿瘤局部切除术;位于下腔静脉背段者7例,其中2例行右后叶(Ⅵ、Ⅶ段)切除术,2例行Ⅶ、Ⅷ段切除术,3例行Ⅴ、Ⅵ段切除术。观察术中出血量、输血量、手术时间、控制出血方法、术中及术后并发症和死亡发生情况。术后随访,应用寿命表法计算患者生存率。

结果

35例患者均顺利完成手术,无发生手术相关性死亡,无发生下腔静脉或肝静脉破裂导致的空气栓塞和大出血等严重并发症。术中出血量100~600(280)ml,5例输红细胞悬液2~4 U。手术时间135~265(178)min。术中控制出血方法:行第一肝门阻断22例,阻断时间15~35(24)min,阻断次数1~2次;行左半肝门阻断2例,阻断时间分别为10、15 min,均为一次性阻断;行右半肝门阻断4例,阻断时间20~38(28)min,均为2次阻断;另3例右半肝切除者,切肝前切断肝动脉右支和阻断门静脉右支;行全肝血流阻断4例,下腔静脉阻断时间10~18(13)min,均为一次性阻断。术后并发症包括胆漏1例、膈下积液4例、右侧胸腔积液6例,处理后均治愈,无发生出血和感染。术后1年和3年生存率分别为87.8%和63.0%。

结论

手术切除治疗中央型肝癌是有效、安全和可行的。术中应选择合适的手术方式和掌握控制肝脏出血方法。

Objective

To evaluate the safety, feasibility and therapeutic outcome of surgical resection for centrally located hepatocellular carcinoma(HCC).

Methods

A total of 35 cases diagnosed as centrally located HCC were enrolled in this retrospective study, who underwent operations from January 2007 to December 2011 at the Department of General Surgery, Xinhua Hospital Affiliated to Shanghai Jiao Tong University. Local ethical committee approval had been received and that the informed consent of all participating subjects was obtained. The patients included 31 males and 4 females with median age of 64 years old (range: 25-69 years old). Among three patients with HCC located in Couinaud segments Ⅳ and Ⅴ, 2 cases received left hemihepatoectomy and 1 case received local resection. Among 11 patients with HCC located in Couinaud segments Ⅷ, 7 cases underwent hepatic segmentectomy of Ⅷ and the other 4 cases underwent hepatic segmentectomy of Ⅶ and Ⅷ. Among seven patients with HCC located between the right anterior and posterior branch of portal vein, 4 cases received hepatic segmentectomy of Ⅴ and Ⅵ and 3 cases received right hemihepatoectomy plus embolectomy. Two patients had HCC located between the left and right trunk of portal vein, the middle and right hepatic vein, inferior vena cava (IVC). These two cases received local resection and one of them underwent right and left liver split following resection. Among seven patients with HCC located in apical segment of IVC, 2 cases received hepatic segmentectomy of Ⅵ and Ⅶ, 2 cases received hepatic segmentectomy of Ⅶ and Ⅷ and the other 3 cases received hepatic segmentectomy of Ⅴ and Ⅵ. The volume of intraoperative blood loss and transfusion, operation time, blood loss control, intraoperative and postoperative complications as well as mortality were observed and recorded. All the patients were followed up and Lift Table method was applied to calculate the survival rate.

Results

All the 35 HCC patients received successful operations and no operative mortality was observed. No complications were observed such as air embolism and massive haemorrhage caused by IVC or rupture of hepatic vein. The intraoperative blood loss were 100-600 ml with the median volume of 280 ml and 5 cases received 2-4 U blood transfusion. The operating time was 135-265 min with the median time of 178 min. The blood loss control methods included 26 cases undergoing the first hepatic portal control (1-2 times hepatic occlusion with time of 15-35 minutes, median time of 24 minutes), 2 cases undergoing left hepatic portal control (olny one-time hepatic occlusion with time of 10, 15 minutes respectively), 4 cases undergoing the right hepatic portal control (2 times of occlusion with time of 20-38 minutes, median time of 28 minutes). The other 3 cases with right hemihepatoectomy had right branch of hepatic artery cut off and the right branch of portal vein blocked up. Four of the 35 patients received total hepatic vascular exclusion with the inferior vena cava blocking time 10-18(13) min for just once. The postoperative complications included 1 case with bile leakage, 4 cases with subdiaphragmatic effusion and 6 cases with right pleural effusion. All patients with complications were cured without haemorrhage and infections. The 1- and 3-year survival rates were 87.8% and 63.0% respectively.

Conclusions

Surgical resection is safe and effective for centrally located HCC. Appropriate techniques and blood loss control should be applied during the operation.

图1 1例中央型肝癌术前和术后CT图像
图2 1例中央型肝癌术中情况
[1]
Wu CC, Ho WL, Chen JT, et al. Mesohepatectomy for centrally located hepatocellular carcinoma:an appraisal of a rare procedure. J Am Coll Surg, 1999, 188(5):508-515.
[2]
Wakai T, Shirai Y, Suda T, et al. Long-term outcomes of hepatectomy vs percutaneous ablation for treatment of hepatocellular carcinoma< or=4 cm. World J Gastroenterol, 2006, 12(4):546-552.
[3]
吴孟超.肝癌外科治疗的近期进展.中国普外基础与临床杂志, 2006, 13(2):125-128.
[4]
Chen XP, Huang ZY. Surgical treatment of hepatocellular carcinoma in China:surgical techniques,indications,and outcomes. Langenbecks Arch Surg, 2005, 390(3):259-265.
[5]
张智坚,吴孟超,陈汉,等.经皮肝穿刺射频消融对肝癌术后复发的治疗意义.中华外科杂志, 2004, 42(7):439-441.
[6]
陈汉,吴孟超,王义.累及第2肝门区巨大肝癌55例手术切除体会.中华普通外科杂志, 2000, 15(9):524-526.
[7]
Yamamoto J, Kosuge T, Takayama T, et al. Perioperative blood transfusion promotes recurrence of hepatocellular carcinoma after hepatectomy. Surgery, 1994, 115(3):303-309.
[8]
Giovanardi RO, Giovanardi HJ, Bozetti M, et al. Intermittent total pedicular clamping in hepatic resections in non-cirrhotic patients. Hepatogastroenterology, 2002, 49(45):764-769.
[9]
Takayama T, Makuuchi M, Inoue K, et al. Selective and unselective clamping in cirrhotic liver. Hepatogastroenterology, 1998, 45(20):376-380.
[10]
Cheng CH, Yu MC, Wu TH, et al. Surgical resection of centrally located large hepatocellular carcinoma. Chang Gung Med J, 2012, 35(2):178-191.
[11]
Miao XY, Hu JX, Dai WD, et al. Null-margin mesohepatectomy for centrally located hepatocellular carcinoma in cirrhotic patients. Hepatogastroenterology, 2011, 58(106):575-582.
[12]
Chau GY, Lui WY, King KL, et al. Evaluation of effect of hemihepatic vascular occlusion and the Pringle maneuver during hepatic resection for patients with hepatocellular carcinoma and impaired liver function. World J Surg, 2005, 29(11):1374-1383.
[13]
樊嘉,周俭,吴志全,等.中央型肝癌的手术切除.中华消化外科杂志, 2007, 6(1):8-12.
[1] 李刘庆, 陈小翔, 吕成余. 全腹腔镜与腹腔镜辅助远端胃癌根治术治疗进展期胃癌的近中期随访比较[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 23-26.
[2] 刘世君, 马杰, 师鲁静. 胃癌完整系膜切除术+标准D2根治术治疗进展期胃癌的近中期随访研究[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 27-30.
[3] 李华志, 曹广, 刘殿刚, 张雅静. 不同入路下行肝切除术治疗原发性肝细胞癌的临床对比[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 52-55.
[4] 常小伟, 蔡瑜, 赵志勇, 张伟. 高强度聚焦超声消融术联合肝动脉化疗栓塞术治疗原发性肝细胞癌的效果及安全性分析[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 56-59.
[5] 王露, 周丽君. 全腹腔镜下远端胃大部切除不同吻合方式对胃癌患者胃功能恢复、并发症发生率的影响[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 92-95.
[6] 冯旺, 马振中, 汤林花. CT扫描三维重建在肝内胆管细胞癌腹腔镜肝切除术中的临床研究[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 104-107.
[7] 杭轶, 杨小勇, 李文美, 薛磊. 可控性低中心静脉压技术在肝切除术中应用的最适中心静脉压[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 813-817.
[8] 公宇, 廖媛, 尚梅. 肝细胞癌TACE术后复发影响因素及预测模型建立[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 818-824.
[9] 李一帆, 朱帝文, 任伟新, 鲍应军, 顾俊鹏, 张海潇, 曹耿飞, 阿斯哈尔·哈斯木, 纪卫政. 血GP73水平在原发性肝癌TACE疗效评价中的作用[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 825-830.
[10] 刘敏思, 李荣, 李媚. 基于GGT与Plt比值的模型在HBV相关肝细胞癌诊断中的作用[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 831-835.
[11] 焦振东, 惠鹏, 金上博. 三维可视化结合ICG显像技术在腹腔镜肝切除术治疗复发性肝癌中的应用[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 859-864.
[12] 陈晓鹏, 王佳妮, 练庆海, 杨九妹. 肝细胞癌VOPP1表达及其与预后的关系[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 876-882.
[13] 袁雨涵, 杨盛力. 体液和组织蛋白质组学分析在肝癌早期分子诊断中的研究进展[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 883-888.
[14] 吴警, 吐尔洪江·吐逊, 温浩. 肝切除术前肝功能评估新进展[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 889-893.
[15] 吴雪云, 胡小军, 范应方. 肝切除术中剩余肝再生能力的评估与预测[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 894-897.
阅读次数
全文


摘要


AI


AI小编
你好!我是《中华医学电子期刊资源库》AI小编,有什么可以帮您的吗?